Advisors Capital Management LLC increased its stake in Medtronic PLC by 2.9% in the third quarter, now owning 435,376 shares. This increase is part of a larger trend of institutional investors growing their positions in Medtronic, which recently beat Q3 revenue and adjusted EPS expectations due to strong demand in cardiovascular and diabetes sectors. Despite some margin pressures, the company reiterated its FY26 guidance and has received analyst upgrades, contributing to a “Moderate Buy” consensus and an average price target of $111.21.
This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
Advisors Capital Management LLC Grows Stake in Medtronic PLC $MDT
Advisors Capital Management LLC increased its stake in Medtronic PLC by 2.9% in the third quarter, now owning 435,376 shares. This increase is part of a larger trend of institutional investors growing their positions in Medtronic, which recently beat Q3 revenue and adjusted EPS expectations due to strong demand in cardiovascular and diabetes sectors. Despite some margin pressures, the company reiterated its FY26 guidance and has received analyst upgrades, contributing to a “Moderate Buy” consensus and an average price target of $111.21.